This analysis revealed that 100% of the MTP-NRP1 treated animals responded to the treatment with 25% of SD (Stable Disease, < −30% growth decrease compared to averaged growth of control tumors) and 75% responded with PR (Partial Response >-30% growth decrease compared to averaged growth of control tumors) including two individuals above or equal to 90% decrease of tumor volume expansion (Figure 2B). The gene discussed is NRP1; the disease is neoplasm.